A. Baillet, L. Gossec, and L. Carmona, Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative, Ann Rheum Dis, vol.75, pp.965-973, 2016.

L. Gossec, A. Baillet, and S. Dadoun, Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France, Joint Bone Spine, vol.83, pp.501-509, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01340133

C. Roubille, V. Richer, and T. Starnino, Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the canadian dermatologyrheumatology comorbidity initiative, J Rheumatol, vol.42, pp.1767-1780, 2015.

C. Daien, C. Hua, and C. Gaujoux-viala, Update of French society for rheumatology recommendations for managing rheumatoid arthritis, Joint Bone Spine, vol.86, pp.135-150, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02264783

M. Dougados, Comorbidities in rheumatoid arthritis, Curr Opin Rheumatol, vol.28, pp.282-288, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02413173

M. Van-onna and A. Boonen, The challenging interplay between rheumatoid arthritis, ageing and comorbidities, BMC Musculoskelet Disord, vol.17, p.184, 2016.

M. Dougados, M. Soubrier, and A. Antunez, Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, vol.73, pp.62-68, 2014.

M. Dougados, M. Soubrier, and E. Perrodeau, Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA), Ann Rheum Dis, vol.74, pp.1725-1733, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01225510

A. Moltó, A. Etcheto, and D. Van-der-heijde, Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study, Ann Rheum Dis, vol.75, pp.1016-1023, 2016.

L. Gossec, M. Soubrier, and F. Foissac, Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients, RMD Open, vol.5, p.914, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02413173

M. Soubrier and E. Bruckert, Should rheumatologists prescribe statins?, Joint Bone Spine, vol.77, pp.93-95, 2010.

, COFER : Collège Français des Enseignants en Rhumatologie, BIBLIOGRAPHIE 1, 2020.

H. Isomäki, Epidemiology of rheumatoid arthritis, Nordisk medicin, vol.109, issue.8-9, pp.215-217, 1994.

F. Guillemin, A. Saraux, P. Guggenbuhl, C. H. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France: 2001. Annals of the Rheumatic Diseases, 2005.

V. F. Derksen, T. W. Huizinga, and D. Van-der-woude, The role of autoantibodies in the pathophysiology of rheumatoid arthritis, Seminars in Immunopathology, 2017.

Y. Tong, L. Zheng, P. Qing, H. Zhao, Y. Li et al., Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis, Frontiers in Cellular and Infection Microbiology, vol.9, 2020.

M. Pedrosa, J. Gomes, P. Laranjeira, C. Duarte, S. Pedreiro et al., Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients, Journal of Tissue Engineering and Regenerative Medicine, vol.14, issue.1, pp.16-28, 2020.

,

B. Combe, Polyarthrite rhumatoïde : clinique et diagnostic, 2007.

, Association des Collèges des Enseignants d'Immunologie des Universités de Langue française, 2010.

M. Sebbag, S. Chapuy-regaud, I. Auger, E. Petit-texeira, C. Clavel et al., Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis, Joint Bone Spine, vol.71, pp.493-502, 2004.

V. Devauchelle-pensec, A. Saraux, S. Alapetite, D. Colin, and P. Le-goff, Les radiographies des mains et des pieds sont-elles un bon critère de diagnostic de la polyarthrite rhumatoïde débutante? Revue du Rhumatisme (Edition Francaise), pp.393-402, 2002.

A. Guermezi, B. Taouli, J. A. Lynch, and C. G. Peterfy, Imaging of bone erosion in rheumatoid arthritis, Seminars in Musculoskeletal Radiology, 2004.

, Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue

M. Magnani, E. Salizzoni, R. Mulè, M. Fusconi, R. Meliconi et al.,

, Ultrasonography detection of early bone erosions in the metacarpophalangeal joints of patients with rheumatoid arthritis, Clinical and experimental rheumatology, vol.22, issue.6, pp.743-751

A. Verdon and K. Lauper, , 2020.

, Revue medicale suisse, vol.16, issue.685, pp.477-480

C. Daien, C. Hua, C. Gaujoux-viala, A. Cantagrel, M. Dubremetz et al., Update of French society for rheumatology recommendations for managing rheumatoid arthritis, Joint Bone Spine, vol.86, issue.2, pp.135-150, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02264783

,

J. L. Nam, S. Ramiro, C. Gaujoux-viala, K. Takase, M. Leon-garcia et al., Efficacy of biological disease-modifying antirheumatic drugs: A systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.73, issue.3, pp.516-528, 2014.

J. S. Smolen, R. Landewé, F. C. Breedveld, M. Buch, G. Burmester et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Annals of the Rheumatic Diseases, vol.73, issue.3, pp.492-509, 2014.

,

C. Gaujoux-viala, L. Gossec, A. Cantagrel, M. Dougados, B. Fautrel et al., Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde, Revue du Rhumatisme (Edition Francaise), vol.81, issue.4, pp.303-312, 2014.

S. Dadoun, N. Zeboulon-ktorza, C. Combescure, M. Elhai, S. Rozenberg et al., Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis, Joint Bone Spine, vol.80, issue.1, pp.29-33, 2013.

,

F. Wolfe, D. M. Mitchell, J. T. Sibley, J. F. Fries, D. A. Bloch et al., The mortality of rheumatoid arthritis, Arthritis & Rheumatism, vol.37, issue.4, pp.481-494, 1994.

S. E. Gabriel, Why do people with rheumatoid arthritis still die prematurely? Annals of the rheumatic diseases, vol.67, pp.30-34, 2008.

,

S. E. Gabriel and K. Michaud, Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases, Arthritis Research and Therapy, 2009.

P. Claudepierre, D. Wendling, M. Breban, P. Goupillle, and M. Dougados, Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: What's in a name? Joint Bone Spine, 2012.

P. Parameswaran and M. Lucke, HLA B27 Syndromes, 2019.

L. Schlosstein, P. I. Terasaki, R. Bluestone, and C. M. Pearson, High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis, New England Journal of Medicine, vol.288, issue.14, pp.704-706, 1973.

,

J. T. Gran, An epidemiological survey of the signs and symptoms of ankylosing spondylitis, Clinical Rheumatology, vol.4, issue.2, pp.161-169, 1985.

,

M. Breban, , 2018.

, La Revue du praticien, vol.68, issue.7, pp.733-736

M. Rudwaleit, D. Van-der-heijde, R. Landewé, J. Listing, N. Akkoc et al., The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.777-783, 2009.

,

S. Linden, . Van-der, H. A. Valkenburg, and A. Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis, Arthritis & Rheumatism, vol.27, issue.4, pp.361-368, 1984.

,

M. Rudwaleit, A. G. Jurik, K. G. Hermann, R. Landewé, D. Van-der-heijde et al., Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: A consensual approach by the ASAS/OMERACT MRI group, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1520-1527, 2009.

D. Wendling, C. Lukas, J. Paccou, P. Claudepierre, L. Carton et al., Recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, Revue du rhumatisme, 2013.

J. Braun, . Van-den, R. Berg, X. Baraliakos, H. Boehm et al., 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.896-904, 2011.

D. Van-der-heijde, J. Sieper, W. P. Maksymowych, M. Dougados, R. Burgos-vargas et al., 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.905-908, 2011.

,

, Les troubles du rythme au cours de la spondylarthrite ankylosante, 2020.

A. Bal?i?nait?, A. Budrikis, E. Rumbinait?, J. Sabaliauskien?, V. Patamsyt? et al., Ankylosing Spondyloarthritis Resulting Severe Aortic Insufficiency and Aortitis: Exacerbation of Ankylosing Spondyloarthritis and Stenosis of the Main Left Coronary Artery after Mechanical Aortic Valve Implantation with Cardiopulmonary Bypass, Case reports in rheumatology, p.9538527, 2020.

L. A. Westerveld, J. J. Verlaan, and F. C. Oner, Spinal fractures in patients with ankylosing spinal disorders: A systematic review of the literature on treatment, neurological status and complications, European Spine Journal. Springer, 2009.

C. Salliot and D. Van-der-heijde, Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic literature research, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1100-1104, 2009.

,

M. Dougados, M. Soubrier, A. Antunez, P. Balint, A. Balsa et al., Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (COMORA), Annals of the Rheumatic Diseases, vol.73, issue.1, pp.62-68, 2014.

A. Moltó, A. Etcheto, D. Van-der-heijde, R. Landewé, . Van-den et al., Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: Results of the international cross-sectional ASAS-COMOSPA study, Annals of the Rheumatic Diseases, vol.75, issue.6, pp.1016-1023, 2016.

,

J. A. Aviña-zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile et al., Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies, Arthritis Care and Research, vol.59, issue.12, pp.1690-1697, 2008.

J. Lindhardsen, O. Ahlehoff, G. H. Gislason, O. R. Madsen, J. B. Olesen et al., The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study, Annals of the rheumatic diseases, vol.70, issue.6, pp.929-963, 2011.

J. Listing, K. Gerhold, and A. Zink, The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment, Rheumatology, vol.52, issue.1, pp.53-61, 2013.

C. J. Wotton and M. J. Goldacre, Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses, Journal of epidemiology and community health, vol.66, issue.12, pp.1177-81, 2012.

,

C. Turesson and E. L. Matteson, Malignancy as a comorbidity in rheumatic diseases, Rheumatology, 2013.

,

I. Del-rincón, K. Williams, M. P. Stern, G. L. Freeman, and A. Escalante, , 2001.

, High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis and Rheumatism, vol.44, issue.12, pp.2737-2745

, , vol.44, 200112.

G. Haugeberg, T. Uhlig, J. A. Falch, J. I. Halse, and T. K. Kvien, Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register, Arthritis and rheumatism, vol.43, issue.3, pp.522-552, 2000.

K. A. Coulson, G. Reed, B. E. Gilliam, J. M. Kremer, and P. H. Pepmueller, Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol.15, issue.4, pp.155-60, 2009.

,

D. D. Gladman and D. D. Gladman, Mortality in psoriatic arthritis, Clin Exp Rheumatol, vol.26, 2008.

C. Prati, P. Claudepierre, T. Pham, and D. Wendling, October 1). Mortality in spondylarthritis, Joint Bone Spine, 2011.

,

D. Mccarey and R. D. Sturrock, Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis, Clinical and Experimental Rheumatology, 2009.

S. Mathieu, L. Gossec, M. Dougados, and M. Soubrier, Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis, Arthritis Care & Research, vol.63, issue.4, pp.557-563, 2011.

A. Bremander, I. F. Petersson, S. Bergman, and M. Englund, Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis, Arthritis Care & Research, vol.63, issue.4, pp.550-556, 2011.

,

A. Jamnitski, D. Symmons, M. J. Peters, N. Sattar, I. Mcilnnes et al., Cardiovascular comorbidities in patients with psoriatic arthritis: A systematic review, Annals of the Rheumatic Diseases, vol.72, issue.2, pp.211-216, 2013.

,

J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson et al., Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses, British Medical Journal, vol.321, issue.7255, pp.199-204, 2000.

,

O. Yousuf, B. D. Mohanty, S. S. Martin, P. H. Joshi, M. J. Blaha et al., High-Sensitivity C-Reactive Protein and Cardiovascular Disease A Resolute Belief or an Elusive Link?, Journal of the American College of Cardiology, vol.62, pp.397-408, 2013.

M. B. Pepys and G. M. Hirschfield, pepys and gideon hirshfield, The Journal of clinical investigation, vol.111, issue.12, pp.1805-1817, 2003.

,

W. G. Dixon, K. D. Watson, M. Lunt, K. L. Hyrich, A. J. Silman et al., Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor ? therapy: Results from the British Society for, Rheumatology Biologics Register. Arthritis and Rheumatism, vol.56, issue.9, pp.2905-2912, 2007.

P. H. Dessein, G. R. Norton, A. J. Woodiwiss, B. I. Joffe, and F. Wolfe, Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis, The Journal of rheumatology, vol.34, issue.5, pp.943-51, 2007.

I. Del-rincón, G. L. Freeman, R. W. Haas, D. H. O'leary, and A. Escalante, Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis, Arthritis & Rheumatism, vol.52, issue.11, pp.3413-3423, 2005.

D. H. Solomon, J. Kremer, J. R. Curtis, M. C. Hochberg, G. Reed et al.,

J. D. Greenberg, Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity, Annals of the Rheumatic Diseases, vol.69, issue.11, pp.1920-1925, 2010.

,

M. J. Peters, I. C. Van-eijk, Y. M. Smulders, E. Serne, B. A. Dijkmans et al., Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis, Journal of Rheumatology, vol.37, issue.1, pp.161-166, 2010.

I. Sari, T. Okan, S. Akar, H. Cece, C. Altay et al., , 2006.

, Impaired endothelial function in patients with ankylosing spondylitis, Rheumatology, issue.3, pp.283-289

I. Essers, C. Stolwijk, A. Boonen, M. L. De-bruin, M. T. Bazelier et al., Ankylosing spondylitis and risk of ischaemic heart disease: A population-based cohort study, Annals of the Rheumatic Diseases, vol.75, issue.1, pp.203-209, 2016.

,

A. Baillet, L. Gossec, L. Carmona, M. De-wit, Y. Van-eijk-hustings et al., Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: A EULAR initiative, Annals of the Rheumatic Diseases, vol.75, issue.6, pp.965-973, 2016.

,

L. Gossec, A. Baillet, S. Dadoun, C. Daien, F. Berenbaum et al., Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01340133

, Joint Bone Spine, vol.83, issue.5, pp.501-509

M. Global, , 2004.

M. F. Doran, C. S. Crowson, G. R. Pond, W. M. O'fallon, and S. E. Gabriel, Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study, Arthritis & Rheumatism, vol.46, issue.9, pp.2287-2293, 2002.

,

K. Au, G. Reed, J. R. Curtis, J. M. Kremer, J. D. Greenberg et al., High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.70, issue.5, pp.785-791, 2011.

,

A. Strangfeld, M. Eveslage, M. Schneider, H. J. Bergerhausen, T. Klopsch et al., Treatment benefit or survival of the fittest: What drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?, Annals of the Rheumatic Diseases, vol.70, issue.11, pp.1914-1920, 2011.

W. G. Dixon, K. Watson, M. Lunt, K. L. Hyrich, A. J. Silman et al.,

, Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for, Rheumatology Biologics Register. Arthritis and Rheumatism, vol.54, issue.8, pp.2368-2376, 2006.

K. G. Saag, R. Koehnke, J. R. Caldwell, R. Brasington, L. F. Burmeister et al., Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events, The American Journal of Medicine, vol.96, issue.2, pp.90131-90138, 1994.

J. B. Galloway, K. L. Hyrich, L. K. Mercer, W. G. Dixon, B. Fu et al., Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: Updated results from the British Society for Rheumatology Biologics Register with special emph, Rheumatology, vol.50, issue.1, pp.124-131, 2011.

,

C. Salliot, M. Dougados, and L. Gossec, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: Meta-analyses of randomised placebo-controlled trials, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.25-32, 2009.

,

L. Campbell, C. Chen, S. S. Bhagat, R. A. Parker, and A. J. Östör, Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials, Rheumatology, vol.50, issue.3, pp.552-62, 2011.

,

A. Fouque-aubert, L. Jette-paulin, C. Combescure, A. Basch, J. Tebib et al., Serious infections in patients with ankylosing spondylitis with and without TNF blockers: A systematic review and meta-analysis of randomised placebocontrolled trials. Annals of the Rheumatic Diseases, 2010.

V. Lemaire, Oncologic risk of drugs used in rheumatology, 2008.

J. Askling, M. Fored, L. Brandt, E. Baecklund, L. Bertilsson et al., Risks of solid cancers in patients with rheumatoid arthritis and following treatment with tnf-antagonists, Ann Rheum Dis, 2005.

, Ostéoporose dans les rhumatismes inflammatoires chroniques, 2020.

T. P. Van-staa, H. G. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, , 2000.

, Use of oral corticosteroids and risk of fractures, Journal of Bone and Mineral Research, vol.15, issue.6, pp.993-1000

M. A. Van-der-weijden, T. A. Claushuis, T. Nazari, W. F. Lems, B. A. Dijkmans et al., High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: A systematic review, Clinical Rheumatology, 2012.

J. Gratacós, A. Collado, F. Pons, M. Osaba, R. Sanmartí et al., Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup study, Arthritis & Rheumatism, vol.42, issue.11, pp.2319-2324, 1999.

, , vol.42, 199911.

R. Will, A. K. Bhalla, R. Palmer, F. Ring, and A. Calin, OSTEOPOROSIS IN EARLY ANKYLOSING SPONDYLITIS: A PRIMARY PATHOLOGICAL EVENT? The Lancet, vol.334, pp.92932-92934, 1989.

J. A. Finkelstein, J. R. Chapman, and S. Mirza, Occult vertebral fractures in ankylosing spondylitis, Spinal Cord, vol.37, issue.6, pp.444-447, 1999.

,

J. S. Young, D. J. Cheshire, J. A. Pierce, and J. M. Vivian, Cervical ankylosis with acute spinal cord injury, Paraplegia, vol.15, issue.2, pp.133-146, 1977.

,

C. Roux and K. Briot, Osteoporosis in inflammatory rheumatism, Revue du Rhumatisme, 2015.

,

M. Dougados, M. Soubrier, E. Perrodeau, L. Gossec, F. Fayet et al., Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA), vol.74, pp.1725-1758, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01225510

,

L. Gossec, M. Soubrier, F. Foissac, A. Molto, P. Richette et al., Screening for and management of comorbidities after a nurseled program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients, RMD open, vol.5, issue.2, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02413173

Y. Jiang, P. Zhang, L. Tu, Q. Lv, J. Qi et al., Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis, J, 2018.

, Clinical Rheumatology, vol.37, issue.2, pp.423-428

M. A. Blum, D. Koo, and J. A. Doshi, Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review, Clinical Therapeutics. Excerpta Medica Inc, 2011.

,

A. L. Betegnie, A. Gauchet, A. Lehmann, L. Grange, M. Roustit et al., Why do patients with chronic inflammatory rheumatic diseases discontinue their biologics? An assessment of patients' adherence using a self-report questionnaire, Journal of Rheumatology, vol.43, issue.4, pp.724-730, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02007478

,

F. Salaffi, M. Carotti, M. Di-carlo, S. Farah, and M. Gutierrez, Adherence to anti-tumor necrosis factor therapy administered subcutaneously and associated factors in patients with rheumatoid arthritis, Journal of Clinical Rheumatology, vol.21, issue.8, pp.419-425, 2015.

, Rapport sur la Santé dans le Monde

S. Joplin, R. Van-der-zwan, F. Joshua, and P. K. Wong, Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound, BioMed research international, p.150658, 2015.

Y. Song, E. Reifsnider, S. Zhao, X. Xie, and H. Chen, A randomized controlled trial of the Effects of a telehealth educational intervention on medication adherence and disease activity in rheumatoid arthritis patients, Journal of Advanced Nursing, 2020.

N. Taibanguay, S. Chaiamnuay, P. Asavatanabodee, and P. Narongroeknawin, Effect of patient education on medication adherence of patients with rheumatoid arthritis: A randomized controlled trial, Patient Preference and Adherence, vol.13, pp.119-129, 2019.

T. Koncz, M. Pentek, V. Brodszky, K. Ersek, E. Orlewska et al., Adherence to biologic DMARD therapies in rheumatoid arthritis, Expert Opinion on Biological Therapy, 2010.

M. D. Iversen, A. Hammond, and N. Betteridge, Self-management of rheumatic diseases: State of the art and future perspectives, Annals of the Rheumatic Diseases, 2010.

Y. Van-eijk-hustings, A. Van-tubergen, C. Boström, E. Braychenko, B. Buss et al., EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.13-19, 2012.

S. Shoor and K. R. Lorig, Self-care and the doctor-patient relationship, 2002.

J. Barlow, C. Wright, J. Sheasby, A. Turner, and J. Hainsworth, Selfmanagement approaches for people with chronic conditions: A review, Patient Education and Counseling, vol.48, issue.2, pp.32-32, 2002.

M. Underner, J. Perriot, G. Peiffer, J. C. Meurice, and B. Dautzenberg, Tabagisme et observance du traitement antituberculeux. Revue des Maladies Respiratoires, 2016.

,